Determination of atomoxetine in human plasma by a high performance liquid chromatographic method with ultraviolet detection using liquid-liquid extraction

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 854, Issue 1-2, 2007, Pages 128-134

  Guo, Wei ^a   Li, Wenbiao ^a   Guo, Guixin ^a   Zhang, Jun ^a   Zhou, Beilei ^a   Zhai, Yimin ^a   Wang, Chuanyue ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atomoxetine; HPLC; Liquid liquid extraction; Pharmacokinetic

Indexed keywords

DIAGNOSIS; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL PROBLEMS; PHARMACOKINETICS; PLASMA (HUMAN); ULTRAVIOLET RADIATION;

ATOMOXETINE; LIQUID LIQUID EXTRACTION; MAPROTILINE; MOBILE PHASE;

DRUG PRODUCTS;

ACETONITRILE; ATOMOXETINE; ETHER; MAPROTILINE; PHOSPHATE BUFFERED SALINE; PSYCHOTROPIC AGENT;

ACCURACY; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STANDARD; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ADRENERGIC UPTAKE INHIBITORS; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALE; PROPYLAMINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 34250822222     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.04.007     Document Type: Article

References (23)

1. FDA. Consumer 37 (2003) 4
2. American Academy of Pediatrics, Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder, Pediatrics 105 (2000) 1158.
3. Dwivedi K.N., and Banhatti R.G. Arch. Dis. Child. 90 (2005) i10
4. Hu Y.Z., Wu H.R., and Yu J.G. Chin. J. School Doctor 5 (1998) 321
5. Lu L., Shi Q.J., Tao F.F., Yin P., and Yin S.X. Chin. Mental Health J. 4 (2006) 221
6. Barkley R.A. J. Clin. Psychiatry 63 (2002) 36
7. Jadad A.R., Boyle M., Cunningham C., Kim M., and Schachar R. Evid. Rep. Technol. Assess. (Summ.) 11 (1999) 1
8. Giros B., and Caron M.G. Trends Pharmacol. Sci. 14 (1993) 43
9. Wong D.T., Threlkeld P.G., Best K.L., and Bymaster F.P. J. Pharmacol. Exp. Ther. 222 (1982) 61
10. Gehlert D.R., Schober D.A., and Gackenheimer S.L. J. Neurochem. 64 (1995) 2792
11. Heil S.H., Holms H.W., Bickel W.K., Higgins S.T., Badger G.J., Laws H.F., and Faries D.E. Drug Alcohol Depend. 67 (2002) 149
12. Chalon S.A., Desager J.P., DeSante K.A., Frye R.F., Witcher J., Long A.J., Sauer J.M., Golnez J.L., Smith B.P., Thomasson H.R., and Horsmans Y. Clin. Pharmacol. Ther. 73 (2003) 178
13. Belle D.J., Ernest C.S., Sauer J.M., Smith B.P., Thomasson H.R., and Witcher J.W. J. Clin. Pharmacol. 42 (2002) 1219
14. Sauer J.M., Long A.J., Ring B., Sanburn N.P., DeSante K.A., Petullo D., VandenBranden M.R., Jensen C.B., Wrighton S.A., Smith B.P., Read H.A., and Witcher J.W. J. Pharmacol. Exp. Ther. 308 (2004) 410
15. Farid N.A., Bergstrom R.F., Ziege E.A., Parli C.J., and Lemberger L. J. Clin. Pharmacol. 25 (1985) 296
16. Witcher J.W., Long A.J., Sauer J.M., Heilgenstein J., Wilens T., Spencer T., and Biederman J. J. Child. Adolesc. Psychopharmacol. 13 (2003) 53
17. Sauer J.M., Ring B.J., and Witcher J.W. Clin. Pharmacokinet. 44 (2005) 571
18. Mullen J.H., Shugert R.L., Ponsler G.D., Li Q., Sundaram B., Coales H.L., Yakupkovic J.E., Lelacheur R.M., Wheeler W.J., Belas F.J., and Sauer J.M. J. Pharm. Biomed. Anal. 38 (2005) 720
19. Zhu H.J., Wang J.S., Donovan J.L., Devane C.L., Gibson B.B., and Markowitz J.S. J. Chromatogr. B 846 (2006) 351
20. Patel C., Patel M., Rani S., Nivsarkar M., and Padh H. J. Chromatogr. B 850 (2007) 356
21. Sauer J.M., Ponsler G.D., Mattiuz E.L., Long A.J., Witcher J.W., Thomasson H.R., and Desante K.A. Drug. Metab. Dispos. 31 (2003) 98
22. Ring B.J., Gillespie J., Eckstein J.A., and Wrighton S.A. Drug. Metab. Dispos. 30 (2002) 319
23. Bertilsson L. Clin. Pharmacokinet. 29 (1995) 192